Best Practice & Research Clinical Rheumatology
Volume 21, Issue 6 , Pages 1093-1108 , December 2007

The contribution of capillaroscopy to the differential diagnosis of connective autoimmune diseases

  • Maurizio Cutolo, MD (Professor of Internal Medicine and Rheumatology, Director of Research Laboratory and Clinical Academic Unit of Rheumatology)

      Affiliations

    • Corresponding Author InformationCorresponding author. Research Laboratory and Clinical Academic Unit of Rheumatology, Department of Internal Medicine, University of Genova, Viale Benedetto XV 6, 16132 Genova, Italy. Tel.: +39 010 353 7994; Fax: +39 010 353 8885.
  • ,
  • Alberto Sulli, MD (Assistant Professor of Rheumatology)
  • ,
  • Maria Elena Secchi, MD (Postgraduate in Rheumatology)
  • ,
  • Monica Olivieri, MD (Postgraduate in Rheumatology)
  • ,
  • Carmen Pizzorni, MD (PhD Staff Member)

References 

  1. Cortes S, Cutolo M. Capillaroscopic patterns in rheumatic diseases. Acta Reumatológica Portuguesa. 2007;32:29–36
  2. Silman A, Holligan S, Brennan P, Maddison P. Prevalence of symptoms of Raynaud's phenomenon in general practice. BMJ (Clinical Research Ed.). 1990;301:590–592
  3. Maricq HR, Carpentier PH, Weinrich MC, et al. Geographic variation in prevalence of Raynaud's phenomenon: a 5 region comparison. The Journal of Rheumatology. 1997;24:879–889
  4. Le Roy EC, Medsger TA. Raynaud's phenomenon: a proposal for classification. Clinical and Experimental Rheumatology. 1992;10:485–488
  5. Planchon B, Pistorius MA, Beurrier P, et al. Primary Raynaud's phenomenon: age of onset and pathogenesis in a prospective study of 424 patients. Angiology. 1994;45:677–686
  6. Kallenberg CG. Early detection of connective tissue disease in patients with Raynaud's phenomenon. Rheumatic Disease Clinics of North America. 1990;16:11–30
  7. Spencer-Green G. Outcomes in primary Raynaud's phenomenon a meta-analysis and the frequency, rates, and predictors of transition to secondary disease. Archives of Internal Medicine. 1998;158:595–600
  8. Zufferey P, Depairon M, Chamot AM, et al. Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities: a six-year follow-up study. Clinical Rheumatology. 1992;11:536–541
  9. Baron M, Bell M, Bookman A, et al. Office capillaroscopy in systemic sclerosis. Clinical Rheumatology. 2007;26:1268–1274
  10. Colwell JA, Halusshka PV, Sarji KE, et al. Vascular disease in diabetes. Pathophysiological mechanisms and therapy. Archives of Internal Medicine. 1979;139:225–230
  11. Maricq HR. Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis & Rheumatism. 1981;24:1159–1165
  12. Ryan TJ. Microcirculation in psoriasis: blood vessels, lymphatics and tissue fluid. Pharmacology & Therapeutics. 1980;10:27–64
  13. Houtman PM, Kallenberg CGM, Fidler V, et al. Diagnostic significance of nailfold capillary patterns in patients with RP: an analysis of patterns discriminating patients with and without connective tissue disease. The Journal of Rheumatology. 1986;13:556–563
  14. Jayson MIV. The microcirculation in systemic sclerosis. Clinical and Experimental Rheumatology. 1984;2:85–91
  15. Chen ZY, Silver RM, Ainsworth SK, et al. Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. American Journal of Medicine. 1984;77:812–822
  16. Bombardieri S, Medsger TA, Silman AJ, et al. The assessment of the patient with systemic sclerosis. Introduction. Clinical and Experimental Rheumatology. 2003;21(3 supplement 29):S2–S4
  17. Blann AD, Illinworth K, Jayson MIV. Mechanisms of endothelial damage in systemic sclerosis and Raynaud's phenomenon. The Journal of Rheumatology. 1993;20:1325–1330
  18. Carpentier PH, Maricq HR. Microvasculature in systemic sclerosis. Rheumatic Disease Clinics of North America. 1990;16:75–91
  19. Maricq HR, Le Roy EC, D'Angelo WA, et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis & Rheumatism. 1980;23:183–189
  20. Andrade LEC, Gabriel A, Assad RL, et al. Panoramic nailfold capillaroscopy: a new reading method and normal range. Seminars in Arthritis and Rheumatism. 1990;20:21–31
  21. Kabasakal Y, Elvins DM, Ring EFJ, et al. Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Annals of the Rheumatic Diseases. 1996;55:507–512
  22. Cutolo M, Sulli A, Pizzorni C, et al. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. The Journal of Rheumatology. 2000;27(1):155–160
  23. Bollinger A, Fagrell B. Collagen vascular disease and related disorders. In: Clinical capillaroscopy. Hogrefe & Huber Publ.; 1990;p. 121–143
  24. Cutolo M, Sulli A, Secchi ME, et al. Capillaroscopy and rheumatic diseases: state of the art. Zeitschrift für Rheumatologie. 2006;65:290–296
  25. Nobili F, Cutolo M, Sulli A, et al. Impaired quantitative cerebral blood flow in scleroderma patients. Journal of the Neurological Sciences. 1997;152:63–71
  26. Sulli A, Savarino V, Cutolo M. Lack of correlation between gastric Helicobacter pylori infection and primary or secondary Raynaud's phenomenon in patients with systemic sclerosis. The Journal of Rheumatology. 2000;27:1820–1821
  27. Cutolo M, Nobili F, Sulli A, et al. Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology. 2000;39:1366–1373
  28. Filaci G, Cutolo M, Basso M, et al. Long-term treatment of patients affected by systemic sclerosis with cyclosporin A. Rheumatology. 2001;40:259–260
  29. Distler O, Del Rosso A, Giacomelli R, et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Research. 2002;4:R11
  30. Nagy Z, Czirjak L. Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud's disease. Journal of European Academy of Dermatology and Venereology. 2004;18:62–68
  31. Klyscz T, Bogenschutz O, Junger M, Rassner G. Microangiopathic changes and functional disorders of nailfold capillaries in dermatomyositis. Der Hautarzt. 1996;47:289–293
  32. Bergman R, Sharony L, Schapira D, et al. The handheld dermatoscope as a nail-fold capillaroscopic instrument. Archives of Dermatology. 2003;139:1027–1030
  33. Ingegnoli F, Zeni S, Meani L, et al. Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus. Journal of Clinical Rheumatology. 2005 Dec;11(6):295–298
  34. Riccieri V, Spadaro A, Ceccarelli F, et al. Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile. Lupus. 2005;14(7):521–525
  35. Furtado RN, Pucinelli ML, Cristo VV, et al. Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients. Lupus. 2002;11:35–41
  36. Bongard O, Bounameaux H, Miescher PA, et al. Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus. Lupus. 1995;4:14–21
  37. Candela M, Pansoni A, De Carolis ST, et al. Nailfold capillary microscopy in patients with antiphospholipid syndrome. Recenti Progressi in Medicina. 1998;89:444–449
  38. Sulli A, Pizzorni C, Cutolo M. Nailfold videocapillaroscopy abnormalities in patients with antiphospholipid antibodies. The Journal of Rheumatology. 2000;27:1574–1576
  39. Vaz JL, Dancour MA, Bottino DA, Bouskela E. Nailfold videocapillaroscopy in primary antiphospholipid syndrome (PAPS). Rheumatology (Oxford). 2004;43:1025–1027
  40. Asherson RA, Pierangeli SS, Cervera R. Is there a microangiopathic antiphospholipid syndrome?. Annals of the Rheumatic Diseases. 2007;66:429–432
  41. Tektonidou M, Kaskani E, Skopouli FN, et al. Microvascular abnormalities in Sjogren's syndrome: nailfold capillaroscopy. Rheumatology (Oxford). 1999;38:826–830
  42. Capobianco KG, Xavier RM, Bredemeier M, et al. Nailfold capillaroscopic findings in primary Sjogren's syndrome: clinical and serological correlations. Clinical and Experimental Rheumatology. 2005;23:789–794
  43. Rossi D, Mansouri M, Baldovino S, et al. Nailfold videocapillaroscopy in mixed cryoglobulinaemia. Nephrology Dialysis Transplantation. 2004;19:2245–2249
  44. Salli L, Raimondi F, Pappalardo A. Periungual capillaroscopy in psoriatic arthritis. Clinica Terapeutica. 1999;150:409–412
  45. Bhushan M, Moore T, Herrick AL, Griffiths CE. Nailfold video capillaroscopy in psoriasis. British Journal of Dermatology. 2000;142:1171–1176
  46. Altomonte L, Zoli A, Galossi A, et al. Microvascular capillaroscopic abnormalities in rheumatoid arthritis patients. Clinical and Experimental Rheumatology. 1995;13:83–86
  47. Dinc A, Melikoglu M, Korkmaz C, et al. Nailfold capillary abnormalities in patients with familial Mediterranean fever. Clinical and Experimental Rheumatology. 2001;19(5 supplement 24):S42–S44
  48. Cutolo M, Grassi W, Matucci Cerinic M. Raynaud's phenomenon and the role of capillaroscopy. Arthritis & Rheumatism. 2003;48:3023–3030
  49. Hirschl M, Hirschl K, Lenz M, et al. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance. Arthritis & Rheumatism. 2006;54:1974–1981
  50. Cutolo M, Pizzorni C, Sulli A. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl, et al. Arthritis & Rheumatism. 2007;56:2102–2103
  51. Cutolo M, Pizzorni C, Sulli A. Capillaroscopy. Best Practice & Research. Clinical Rheumatology. 2005;19:437–452
  52. Cutolo M, Pizzorni C, Tuccio M, et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford). 2004;43:719–726

PII: S1521-6942(07)00109-X

doi: 10.1016/j.berh.2007.10.001

Best Practice & Research Clinical Rheumatology
Volume 21, Issue 6 , Pages 1093-1108 , December 2007